Delivery Order SPE2DE24D0013-SPE2D625F3TKV
- Not listed
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $40,800 by the Defense Department's Medical Supply Chain on August 14, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing solutions with an ultimate completion date of August 21, 2025. This award includes no set-aside designation and represents work to be...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,096.80 firm fixed-price delivery order by the Medical Supply Chain (Defense) on June 30, 2025, with an ultimate completion date of July 15, 2025. The contract, designated as XPCOV2/FLU/RSV-10, carries no set-aside designation and specifies performance in Sunnyvale, California. This delivery order pertains to molecular diagnostic testing capabilities for COVID-19, influenza, and respiratory...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $6,631.72 firm fixed-price delivery order by the Defense Department's Medical Supply Chain on September 5, 2025, with an ultimate completion date of September 12, 2025. The contract, designated XPCOV2/FLU/RSV-10, calls for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic products and services, with performance occurring at Cepheid's Sunnyvale facility. This award carries...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 on September 10, 2025, by the Medical Supply Chain, a defense-focused federal agency. This delivery order, designated XPCOV2/FLU/RSV-10 with an ultimate completion date of September 17, 2025, is associated with Cepheid's larger Indefinite Delivery Vehicle (IDV) contract with the Veterans Affairs Veterans Integrated Service Network 21, valued at $2.5...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $13,179.30 firm fixed-price delivery order by the Medical Supply Chain (a Defense agency) on May 2, 2025, with completion scheduled for May 9, 2025. The delivery order, designated 4568136320 ! XPCOV2/FLU/RSV-10, is for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing solutions and carries no set-aside designation. The work will be performed in Sunnyvale,...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $5,440 on September 5, 2025, by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The delivery order, identified as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and calls for completion by September 12, 2025. Based on the contract nomenclature and Cepheid's product portfolio, this delivery order...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, received a $7,480 firm fixed-price delivery order from the Medical Supply Chain (Defense) on September 9, 2025, with an ultimate completion date of September 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the procurement of molecular diagnostic solutions, specifically test kits and related supplies for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3TKVDelivery Order
Cepheid, a molecular diagnostic solutions manufacturer based in Sunnyvale, California, received a $6.8K firm fixed-price delivery order from the Defense Logistics Agency (Medical Supply Chain) on September 17, 2025, for the procurement of a KIT XPERT XPRESS COVID-19, Influenza, and RSV molecular biology diagnostic kit. The contract specifies performance in Sunnyvale, California, with an ultimate completion date of September 23, 2025. This award carries no set-aside designation and represents a small-value order consistent with Cepheid's ongoing supply of molecular diagnostic testing solutions to federal healthcare agencies. This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which provide the framework for continuous procurement of molecular diagnostic reagents and assays. Cepheid maintains two significant IDV agreements with VA networks valued at approximately $35.3M combined, enabling rapid fulfillment of diagnostic testing needs across the federal healthcare system. The company's GeneXpert diagnostic platform and associated test kits have become critical infrastructure for detecting infectious diseases including COVID-19, influenza, and respiratory syncytial virus across multiple federal agencies including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/17/25 |